NCI Events

NCI Alliance for Nanotechnology in Cancer Annual Principal Investigator Meeting

The 2024 NCI Alliance for Nanotechnology in Cancer Annual Principal Investigator Meeting will be held at the NCI Shady Grove facility on October 24-25, 2024. The meeting will gather the Alliance investigators and collaborators to present their recent research results as well as to discuss emerging opportunities in cancer nanotechnology.

International Conference on Malignancies in HIV/AIDS (ICMH)

You are invited to join us at the 19th International Conference on Malignancies in HIV/AIDS (ICMH). The meeting will take place October 24-25, 2024, at the Natcher Conference Center on the campus of the National Institutes of Health in Bethesda, Maryland.

Translational Advances in Cancer Prevention Agent Development (TACPAD) – 3rd Biennial Virtual Meeting

The main goals of the meeting are to: 1) Foster the exchange of ideas and potentially new collaborative interactions among leading cancer prevention researchers from basic and clinical research, 2) Highlight new and emerging trends in immunoprevention and chemoprevention as well as new information from clinical trials, and 3) Inform the research community of the significant resources available from the NCI to promote prevention agent development and rapid translation to clinical trials and to engage cancer researchers with novel prevention concepts.

NCI Workshop on Biospecimen Resources for Proteogenomic Characterization

The mission of the Clinical Proteomic Tumor Analysis Consortium (CPTAC) is to enhance the understanding of the molecular mechanisms of cancer development through integrated analysis of genomics and proteomics (proteogenomics), and imaging; generate community resources of data, protocols, and reagents; and accelerate the clinical translation of proteomic technologies.

Women’s Health Course

The Women’s Health course covers important topics in women’s health, such as menopause, menstrual disorders, endometriosis, chronic pelvic pain, cardiovascular health, mental health, immune health, and ovarian, breast, and cervical cancers. Participants will learn how to prevent, diagnose, and treat women’s health disorders. Where possible, material will be presented about current aspects of clinical research. The participation of NIH fellows who want to learn more about women’s health is encouraged.

Sallie Rosen Kaplan Postdoctoral Fellowship for Women Scientists in Cancer Research

The Sallie Rosen Kaplan (SRK) Postdoctoral Fellowship for Women Scientists in Cancer Research was established in 2000 through the estate of Sallie Rosen Kaplan.

2024 NCI Cohort Consortium Annual Meeting

The meeting is sponsored by the Division of Cancer Control and Population Sciences (Epidemiology and Genomics Research Program) and the Division of Cancer Epidemiology and Genetics of the National Cancer Institute (NCI), with a goal to bring together consortium researchers to discuss emerging science, scientific progress of consortium projects and groups, gaps, and opportunities for collaboration across studies, and ideas for new scientific projects in the consortium.

Cancer AI Conversations

“Cancer AI Conversations” are bimonthly, 1-hour virtual events featuring timely topics related to the application of artificial intelligence in cancer research. Each event features short talks from 2-4 subject matter experts offering diverse perspectives on the session topic. These talks will be followed by a moderated panel discussion.

Studying the Context and Complexity of Oncogenes and Oncogene Addiction Paradigms in MalignanciEs (SCOPE) Think Tank Meeting

The SCOPE think tank meeting will be held at the National Cancer Institute (Shady Grove Campus,) on December 9-10, 2024.

Transformative Microsystem Technologies for Cancer Diagnostics, Monitoring Treatment Response, and Management

The first day of the workshop is dedicated to showcasing the latest advancements in microsystem technologies and their application in cancer diagnosis and management. The second day focuses on addressing the challenges and barriers that delay the clinical adoption of microsystem technologies.

Consortium for Cancer Implementation Science Annual Meeting

The Consortium for Cancer Implementation Science (CCIS) annual meeting taking place in-person from February 26-28, 2025, in Winston-Salem, North Carolina will be hosted by Wake Forest University School of Medicine and Atrium Health Wake Forest Baptist Comprehensive Cancer Center. The annual meeting provides an opportunity for researchers, practitioners, and investigators to collaborate and advance the field of implementation science (IS) in cancer.

13th Annual Symposium on Global Cancer Research

ASGCR 2025 Theme: New Models for Participatory Research in Global Oncology: Elevating the Voices of Patients and Providers

By elevating the voice of patients and providers in low- and middle-income countries (LMICs), cancer research can become more responsive, locally relevant, culturally sensitive, empowering, and effective. This also contributes to addressing historical challenges in global oncology, as research models have often focused on clinical data without incorporating the leadership, perspectives, and experiences of those directly impacted by cancer, such as patients, caregivers and providers. At ASGCR 2025, we will showcase collaborative models, where those living with cancer and delivering care for those affected by cancer are active partners and contribute valuable expertise based on their lived experience.